tirzepatide alternatives weight loss 2025 Tops Semaglutide for Loss: SURMOUNT-5 7 Best Tirzepatide Alternatives For
Description
Published May 28, 2025
placebo Population: T2D with established CVD or high CV risk Study Objectives: Primary Endpoint: Time to first occurrence of 3-point MACE (CV death, non-fatal MI, non-fatal stroke) Secondary Endpoints: Heart failure hospitalization, all-cause mortality, kidney outcomes Anticipated Results: Expected completion 2025
FDA Reporting You or your healthcare provider can report suspected adverse reactions to the FDAs MedWatch Program at 1-800-FDA-1088 or via www.fda.gov/medwatch
Your pharmacist can also provide practical advice on managing your medication during travel or schedule changes
It is also an option for those looking to lose weight as part of their diabetes management plan
This record will help you and your clinician understand what changed and when
